633. Deputy Aengus Ó Snodaigh asked the Minister for Health the reason for the continued failure to approve and purchase the drug selpercatinib as a targeted treatment for medullary thyroid cancer and small cell lung cancer for patients in Ireland; the number of patients undergoing treatment for these forms of cancer who would benefit from such treatment; the cost of providing it; if she will ensure the approval and funding are provided to facilitate the provision of this treatment in Ireland; and if not, if she will amend the criteria for the treatment abroad scheme to allow such patients to receive this medication elsewhere in the European Union or in the United Kingdom.; and if she will make a statement on the matter. [67988/25]

Summary

633. Deputy Aengus Ó Snodaigh asked the Minister for Health the reason for the continued failure to approve and purchase the drug selpercatinib as a targeted treatment for medullary thyroid cancer and small cell lung cancer for patients in Ireland; the number of patients undergoing treatment for these forms of cancer who would benefit from such treatment; the cost of providing it; if she will ensure the approval and funding are provided to facilitate the provision of this treatment in Ireland; and if not, if she will amend the criteria for the treatment abroad scheme to allow such patients to receive this medication elsewhere in the European Union or in the United Kingdom.; and if she will make a statement on the matter. [67988/25]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 2 December 2025

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.